CPMI and IOSCO published the third batch, consultative report on harmonization of critical OTC derivatives data elements (other than Unique Transaction Identifier, or UTI, and the Unique Product Identifier, or UPI). This report complements the consultative report on Harmonization of key OTC derivatives data elements (other than UTI and UPI)—first batch, on Harmonization of critical OTC derivatives data elements (other than UTI and UPI)—second batch, and on Harmonization of the Unique Transaction Identifier, along with the two consultative reports on harmonization of the UPI. CPMI and IOSCO issued the final technical guidance on UTI in February 2017 and plan to issue the one on UPI around mid-2017 and one on critical data elements in early 2018.
The report is a further step toward fulfilling the Group of 20's (G20) 2009 commitment to report all OTC derivatives contracts to, with the aim of improving transparency, mitigating systemic risk, and preventing market abuse. Aggregation of the data reported across trade repositories will help ensure that authorities can obtain a comprehensive view of trade repositories in the OTC derivatives market. The CPMI, IOSCO, and FSB have, in recent years, published reports to lay the foundation for the harmonization work on key OTC derivatives data elements for meaningful aggregation on a global basis, including the 2012 CPSS-IOSCO report on OTC derivatives data reporting and aggregation requirements, the 2013 CPSS-IOSCO report on Authorities' access to trade repository data, and the 2014 FSB Feasibility study on approaches to aggregate OTC derivatives data. Following the 2014 feasibility study, the FSB asked the CPMI and IOSCO to develop global guidance on the harmonization of data elements reported to trade repositories and important for the aggregation of data by authorities, including the UTI and the UPI. This consultative report is part of the Harmonization Group's response to that mandate.
Comments Due Date: August 30, 2017
Keywords: International, Trade Repository, OTC Derivatives, CPMI, IOSCO, Securities, UPI, UTI
BCBS amended the guidelines on sound management of risks related to money laundering and financing of terrorism (ML/FT).
US Agencies (Farm Credit Administration, FDIC, FED, FHFA, and OCC) finalized changes to the swap margin rule to facilitate implementation of prudent risk management strategies at banks and other entities with significant swap activities.
PRA published a letter that builds on the expectations set out in the supervisory statement (SS3/19) on enhancing banks' and insurers' approaches to managing the financial risks from climate change.
EBA finalized the guidelines on treatment of structural foreign-exchange (FX) positions under Article 352(2) of the Capital Requirements Regulation (CRR).
FSB published a statement on the impact of COVID-19 pandemic on global benchmark transition.
IAIS published the list of Internationally Active Insurance Groups (IAIGs) publicly disclosed by group-wide supervisors.
FED has temporarily revised the reporting form on consolidated financial statements for holding companies (FR Y-9C; OMB No. 7100-0128).
EC launched a consultation on the review of the key elements of Solvency II Directive, with the comment period ending on October 21, 2020.
ECB launched a consultation on the guide that sets out supervisory approach to consolidation projects in the banking sector.
IAIS published technical specifications, questionnaires, and templates for 2020 Insurance Capital Standard (ICS) and Aggregation Method data collections.